Get the Stockscreener App
52.62
1.27%
0.66
After Hours:
52.65
0.03
+0.06%
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $52.62, with a volume of 13.08M.
It is up +1.27% in the last 24 hours and up +19.48% over the past month.
See More
Previous Close:
$51.96
Open:
$52.23
24h Volume:
13.08M
Relative Volume:
1.01
Market Cap:
$62.83B
Revenue:
$368.91B
Net Income/Loss:
$5.02B
P/E Ratio:
13.36
EPS:
3.94
Net Cash Flow:
$1.69B
1W Performance:
+9.60%
1M Performance:
+19.48%
6M Performance:
-14.58%
1Y Performance:
-31.65%
1-Day Range:
$51.80
$52.89
1-Week Range:
$49.52
$52.89
52-Week Range:
$43.56
$80.75
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Compare CVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
52.62 | 62.83B | 368.91B | 5.02B | 1.69B | 3.94 |
|
UNH
Unitedhealth Group Inc
|
509.76 | 469.12B | 400.28B | 14.41B | 20.71B | 15.50 |
|
ELV
Elevance Health Inc
|
385.29 | 89.36B | 174.02B | 6.42B | 871.00M | 27.43 |
|
CI
Cigna Group
|
283.99 | 78.99B | 229.75B | 3.04B | 5.18B | 10.60 |
|
HUM
Humana Inc
|
282.63 | 34.03B | 115.01B | 1.36B | -4.34B | 11.29 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-03-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Nov-18-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| May-07-24 | Downgrade | TD Cowen | Buy → Hold |
| May-02-24 | Downgrade | UBS | Buy → Neutral |
| May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Dec-22-23 | Initiated | HSBC Securities | Buy |
| Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| May-26-23 | Initiated | Piper Sandler | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Dec-01-21 | Initiated | Seaport Research Partners | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
| Sep-17-20 | Initiated | Piper Sandler | Overweight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-10-19 | Reiterated | BofA/Merrill | Buy |
| Mar-13-19 | Initiated | Bernstein | Outperform |
| Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-18-18 | Initiated | Barclays | Overweight |
| Nov-29-18 | Resumed | Goldman | Neutral |
| Nov-28-18 | Initiated | Evercore ISI | Outperform |
| Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
| Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
Polianta Ltd Grows Position in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Shares Sold by Trust Co. of Vermont - MarketBeat
CVS Health Co. (NYSE:CVS) Stake Lowered by Albert D Mason Inc. - MarketBeat
CVS Health: One Ugly Chart, Leverage Issues, Trump Problems, Recession/Competition Risks (NYSE:CVS) - Seeking Alpha
Avanza Fonder AB Makes New $4.75 Million Investment in CVS Health Co. (NYSE:CVS) - MarketBeat
Empirical Asset Management LLC Buys 32,860 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
CVS (CVS Health) Forward Dividend Yield % : 5.06% (As of Jan. 19, 2025) - GuruFocus.com
CVS Health Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Is CVS Health (CVS) the Best Fortune 500 Dividend Stock to Buy Right Now? - Insider Monkey
CVS Health (NYSE:CVS) Stock Price Up 1.1%Time to Buy? - MarketBeat
Dividend Roundup: Citigroup, Procter & Gamble, Caterpillar, CVS Health, and more - Seeking Alpha
CVS Health Co. (NYSE:CVS) Stock Holdings Decreased by Gateway Investment Advisers LLC - MarketBeat
Assenagon Asset Management S.A. Lowers Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health (NYSE:CVS) Stock Price Down 0.6%Time to Sell? - MarketBeat
CVS Health Isn't Going To The Dogs - Seeking Alpha
CVS Health (CVS) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Insurance, Pharmacy Benefit Manager Company Stocks Drop Following UnitedHealth's Q4 Revenue Miss: What's Going On? - Benzinga
CVS Health (NYSE:CVS) Stock Price Down 1.7%Here's Why - MarketBeat
FTC to bring lawsuit against CVS, Cigna, and UnitedHealth Group - The American Bazaar
Several Setbacks Dragged CVS Health Corp. (CVS) in Q4 - Insider Monkey
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know - MSN
Oak Thistle LLC Invests $837,000 in CVS Health Co. (NYSE:CVS) - MarketBeat
Claro Advisors LLC Decreases Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Corp. stock rises Wednesday, still underperforms market - MarketWatch
Is CVS Health (CVS) the Hottest Large-Cap Stock So Far in 2025? - Insider Monkey
Healthcare: Sector Looks Undervalued with Pullback After US Election and Obesity Data - Morningstar
CVS Health (NYSE:CVS) Trading Up 1.1%Still a Buy? - MarketBeat
Why UnitedHealth and CVS Are Set to Dominate the $21 Billion Medicare Advantage Surge - Yahoo Canada Finance
CVS Health Corp (CVS)'s Uncertain Future: Understanding the Barriers to Outperformance - GuruFocus.com
CVS stock retains Overweight rating on expected developments - Investing.com
Meyer Handelman Co. Sells 9,103 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Radnor Capital Management LLC Sells 12,479 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
3 Dividend Stocks at Bargain Levels to Defend Your Portfolio - MarketBeat
CVS Health: Current Price Offers Favorable Risk-Reward Profile - Yahoo Finance
Can Integrated Healthcare Stocks Succeed in Public Markets? - Benzinga
CVS CEO Exit Ends Promising Era of Women Heading Pharmacy Chains - MSN
FTC accuses CVS, Cigna, UnitedHealth of abusing middleman role, shares down - MSN
CVS Accused of Illegal Opioid Dispensing in Federal Suit - MSN
What You Need To Know Ahead of CVS Health's Earnings Release - Nasdaq
CVS Health Corp. stock rises Tuesday, still underperforms market - MarketWatch
Do Dr. Oz's Health Care Stocks Create a Conflict of Interest? - MSN
FTC Says CVS, Cigna and UnitedHealth Abuse Middleman Role - Bloomberg
FTC Says CVS, Cigna and UnitedHealth Abuse Middleman Role (3) - Bloomberg Law
FTC says CVS, Cigna, and UnitedHealth abuse middleman role - The Boston Globe
US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain - Yahoo News Canada
FTC Accuses CVS, Cigna, UnitedHealth of Abusing Middleman Role - Bloomberg Law
Why CVS Health (CVS) Led the Monday Upsurge? - MSN
What You Need To Know Ahead Of CVS Health's Earnings Release - Barchart
Oak Asset Management LLC Has $2.48 Million Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Position Reduced by Peddock Capital Advisors LLC - MarketBeat
CVS Health (NYSE:CVS) Stock Price Up 6.3%Time to Buy? - MarketBeat
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.07%
0.99%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):